These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28257991)

  • 21. A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects.
    Kraig E; Linehan LA; Liang H; Romo TQ; Liu Q; Wu Y; Benavides AD; Curiel TJ; Javors MA; Musi N; Chiodo L; Koek W; Gelfond JAL; Kellogg DL
    Exp Gerontol; 2018 May; 105():53-69. PubMed ID: 29408453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ascophyllan functions as an adjuvant to promote anti-cancer effect by dendritic cell activation.
    Zhang W; Okimura T; Xu L; Zhang L; Oda T; Kwak M; Yu Q; Jin JO
    Oncotarget; 2016 Apr; 7(15):19284-98. PubMed ID: 27008707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
    Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
    Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-delivery of tumor antigen and dual toll-like receptor ligands into dendritic cell by silicon microparticle enables efficient immunotherapy against melanoma.
    Zhu M; Ding X; Zhao R; Liu X; Shen H; Cai C; Ferrari M; Wang HY; Wang RF
    J Control Release; 2018 Feb; 272():72-82. PubMed ID: 29325699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles.
    Jewell CM; López SC; Irvine DJ
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15745-50. PubMed ID: 21896725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. mTOR inhibition potentiates cytotoxicity of Vγ4 γδ T cells via up-regulating NKG2D and TNF-α.
    Cao G; Wang Q; Li G; Meng Z; Liu H; Tong J; Huang W; Liu Z; Jia Y; Wei J; Chi H; Yang H; Zhao L; Wu Z; Hao J; Yin Z
    J Leukoc Biol; 2016 Nov; 100(5):1181-1189. PubMed ID: 27256566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. mTOR regulates memory CD8 T-cell differentiation.
    Araki K; Turner AP; Shaffer VO; Gangappa S; Keller SA; Bachmann MF; Larsen CP; Ahmed R
    Nature; 2009 Jul; 460(7251):108-12. PubMed ID: 19543266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of mTOR signaling via rapamycin combined with immunotherapy augments antiglioma cytotoxic and memory T-cell functions.
    Mineharu Y; Kamran N; Lowenstein PR; Castro MG
    Mol Cancer Ther; 2014 Dec; 13(12):3024-36. PubMed ID: 25256739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses.
    Kang S; Ahn S; Lee J; Kim JY; Choi M; Gujrati V; Kim H; Kim J; Shin EC; Jon S
    J Control Release; 2017 Jun; 256():56-67. PubMed ID: 28428066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutral polymer micelle carriers with pH-responsive, endosome-releasing activity modulate antigen trafficking to enhance CD8(+) T cell responses.
    Keller S; Wilson JT; Patilea GI; Kern HB; Convertine AJ; Stayton PS
    J Control Release; 2014 Oct; 191():24-33. PubMed ID: 24698946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delivering all in one: Antigen-nanocapsule loaded with dual adjuvant yields superadditive effects by DC-directed T cell stimulation.
    Paßlick D; Piradashvili K; Bamberger D; Li M; Jiang S; Strand D; R Wich P; Landfester K; Bros M; Grabbe S; Mailänder V
    J Control Release; 2018 Nov; 289():23-34. PubMed ID: 30219277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined OX40L and mTOR blockade controls effector T cell activation while preserving T
    Tkachev V; Furlan SN; Watkins B; Hunt DJ; Zheng HB; Panoskaltsis-Mortari A; Betz K; Brown M; Schell JB; Zeleski K; Yu A; Kirby I; Cooley S; Miller JS; Blazar BR; Casson D; Bland-Ward P; Kean LS
    Sci Transl Med; 2017 Sep; 9(408):. PubMed ID: 28931653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elastin-based protein polymer nanoparticles carrying drug at both corona and core suppress tumor growth in vivo.
    Shi P; Aluri S; Lin YA; Shah M; Edman M; Dhandhukia J; Cui H; MacKay JA
    J Control Release; 2013 Nov; 171(3):330-8. PubMed ID: 23714121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity.
    Prins RM; Craft N; Bruhn KW; Khan-Farooqi H; Koya RC; Stripecke R; Miller JF; Liau LM
    J Immunol; 2006 Jan; 176(1):157-64. PubMed ID: 16365406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of Type 1 Diabetes with Acetalated Dextran Microparticles Containing Rapamycin and Pancreatic Peptide P31.
    Chen N; Kroger CJ; Tisch RM; Bachelder EM; Ainslie KM
    Adv Healthc Mater; 2018 Sep; 7(18):e1800341. PubMed ID: 30051618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.
    Liang R; Xie J; Li J; Wang K; Liu L; Gao Y; Hussain M; Shen G; Zhu J; Tao J
    Biomaterials; 2017 Dec; 149():41-50. PubMed ID: 28992509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory T cells require mammalian target of rapamycin signaling to maintain both homeostasis and alloantigen-driven proliferation in lymphocyte-replete mice.
    Wang Y; Camirand G; Lin Y; Froicu M; Deng S; Shlomchik WD; Lakkis FG; Rothstein DM
    J Immunol; 2011 Mar; 186(5):2809-18. PubMed ID: 21270412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chitosan hydrogel vaccine generates protective CD8 T cell memory against mouse melanoma.
    Highton AJ; Kojarunchitt T; Girardin A; Hook S; Kemp RA
    Immunol Cell Biol; 2015 Aug; 93(7):634-40. PubMed ID: 25708538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
    J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
    Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
    Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.